4/A: CFO Harmon Corrects Viridian Therapeutics Share Count
Insider Transaction Amendment
Viridian Therapeutics' Chief Financial Officer Seth Harmon filed an amended Form 4 to correct his beneficial ownership, adding 1,711 shares of common stock acquired through an employee stock purchase plan.
Summary
- Seth Harmon, Chief Financial Officer of Viridian Therapeutics, Inc. (VRDN), filed an amended Form 4 (Form 4/A).
- The amendment corrects an inadvertent omission of 1,711 shares of common stock from his previously reported beneficial ownership.
- These shares were acquired under the Viridian Therapeutics, Inc. 2016 Employee Stock Purchase Plan.
- The original Form 4 was filed on March 4, 2025, and the earliest transaction date for the omitted shares was March 3, 2025.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as slightly positive due to the increase in insider ownership, albeit a correction, indicating continued executive investment in the company's stock.
Positives
- The correction reflects an increase in beneficial ownership by a key executive, Seth Harmon, adding 1,711 shares of common stock.
- The shares were acquired through an employee stock purchase plan, indicating management's participation and investment in the company.
Negatives
- An initial error in reporting beneficial ownership required an amendment to a previously filed Form 4.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that insider purchases, even small ones or corrections, can sometimes be viewed positively by the market as they signal management's confidence in the company's future prospects. However, the primary purpose of this filing is a compliance correction rather than a strategic move.
Stakeholder Impact
- Shareholders may view the increased insider ownership as a minor positive signal of management confidence.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of earliest transaction for the omitted shares. |
| 03/04/2025 | Date of original Form 4 filing and the amendment filing. |
| 03/04/2026 | Signature date on the amended filing. |
Keywords
Viridian Therapeutics, VRDN, Seth Harmon, Form 4/A, Insider Trading, Beneficial Ownership, Employee Stock Purchase Plan, CFO, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.